

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.20894442 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.82890551 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.73225124 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.56306046 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.43209380 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.21006075 |
| 7 | vocalization behavior (GO:0071625) | 5.12263187 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.07869395 |
| 9 | glutamate secretion (GO:0014047) | 5.02300644 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.82826633 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.80895109 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.69893056 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.59484067 |
| 14 | neuronal action potential propagation (GO:0019227) | 4.46377189 |
| 15 | cellular potassium ion homeostasis (GO:0030007) | 4.41253569 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.37821647 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.32813777 |
| 18 | protein localization to synapse (GO:0035418) | 4.31865469 |
| 19 | exploration behavior (GO:0035640) | 4.24154462 |
| 20 | sodium ion export (GO:0071436) | 4.22962164 |
| 21 | synaptic transmission, glutamatergic (GO:0035249) | 4.21671200 |
| 22 | glutamate receptor signaling pathway (GO:0007215) | 4.20402411 |
| 23 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.17706449 |
| 24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.16261926 |
| 25 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.02789477 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.00352579 |
| 27 | long-term memory (GO:0007616) | 3.98737326 |
| 28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.95414295 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 3.94348127 |
| 30 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.89144673 |
| 31 | gamma-aminobutyric acid transport (GO:0015812) | 3.88550349 |
| 32 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.84212000 |
| 33 | regulation of synapse structural plasticity (GO:0051823) | 3.81176748 |
| 34 | layer formation in cerebral cortex (GO:0021819) | 3.81066087 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.77675694 |
| 36 | neuron cell-cell adhesion (GO:0007158) | 3.76950806 |
| 37 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.66863996 |
| 38 | positive regulation of membrane potential (GO:0045838) | 3.66749790 |
| 39 | regulation of postsynaptic membrane potential (GO:0060078) | 3.65284910 |
| 40 | dendritic spine morphogenesis (GO:0060997) | 3.61908915 |
| 41 | proline transport (GO:0015824) | 3.57755909 |
| 42 | cell communication by electrical coupling (GO:0010644) | 3.57137680 |
| 43 | neurotransmitter transport (GO:0006836) | 3.51850546 |
| 44 | synaptic vesicle endocytosis (GO:0048488) | 3.51838352 |
| 45 | positive regulation of synapse maturation (GO:0090129) | 3.51736757 |
| 46 | activation of protein kinase A activity (GO:0034199) | 3.46326819 |
| 47 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.44353981 |
| 48 | regulation of synaptic plasticity (GO:0048167) | 3.42329150 |
| 49 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.41746038 |
| 50 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.40237200 |
| 51 | long-term synaptic potentiation (GO:0060291) | 3.37801543 |
| 52 | membrane depolarization during action potential (GO:0086010) | 3.34467166 |
| 53 | regulation of ARF protein signal transduction (GO:0032012) | 3.33431152 |
| 54 | neuromuscular process controlling balance (GO:0050885) | 3.33398990 |
| 55 | regulation of neurotransmitter secretion (GO:0046928) | 3.32095685 |
| 56 | neuromuscular process controlling posture (GO:0050884) | 3.31635514 |
| 57 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.22301176 |
| 58 | regulation of neurotransmitter levels (GO:0001505) | 3.21534111 |
| 59 | transmission of nerve impulse (GO:0019226) | 3.21135877 |
| 60 | membrane hyperpolarization (GO:0060081) | 3.19997169 |
| 61 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.18148322 |
| 62 | innervation (GO:0060384) | 3.17789005 |
| 63 | regulation of vesicle fusion (GO:0031338) | 3.15889917 |
| 64 | membrane depolarization (GO:0051899) | 3.15599293 |
| 65 | cerebellar granule cell differentiation (GO:0021707) | 3.15308232 |
| 66 | potassium ion import (GO:0010107) | 3.12759310 |
| 67 | neuron recognition (GO:0008038) | 3.11855833 |
| 68 | dendrite morphogenesis (GO:0048813) | 3.11495550 |
| 69 | activated T cell proliferation (GO:0050798) | 3.09719379 |
| 70 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.07398652 |
| 71 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.06292906 |
| 72 | chemosensory behavior (GO:0007635) | 3.06077732 |
| 73 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.04383449 |
| 74 | regulation of neurotransmitter transport (GO:0051588) | 3.04350947 |
| 75 | prepulse inhibition (GO:0060134) | 3.02934072 |
| 76 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.02106263 |
| 77 | vesicle transport along microtubule (GO:0047496) | 3.01899620 |
| 78 | glycine transport (GO:0015816) | 3.01317752 |
| 79 | response to histamine (GO:0034776) | 3.01023934 |
| 80 | cellular sodium ion homeostasis (GO:0006883) | 3.00716570 |
| 81 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.00104638 |
| 82 | behavioral defense response (GO:0002209) | 2.99974791 |
| 83 | behavioral fear response (GO:0001662) | 2.99974791 |
| 84 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.99905576 |
| 85 | establishment of protein localization to Golgi (GO:0072600) | 2.99237206 |
| 86 | positive regulation of neurotransmitter transport (GO:0051590) | 2.99228433 |
| 87 | axonal fasciculation (GO:0007413) | 2.98518489 |
| 88 | L-amino acid import (GO:0043092) | 2.96995220 |
| 89 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.96914473 |
| 90 | protein K11-linked deubiquitination (GO:0035871) | 2.96225041 |
| 91 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.95267830 |
| 92 | potassium ion homeostasis (GO:0055075) | 2.94606452 |
| 93 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.93265213 |
| 94 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.91571317 |
| 95 | establishment of nucleus localization (GO:0040023) | 2.89989498 |
| 96 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.89706969 |
| 97 | long term synaptic depression (GO:0060292) | 2.89435355 |
| 98 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.87654602 |
| 99 | positive regulation of synaptic transmission (GO:0050806) | 2.87464561 |
| 100 | neuromuscular process (GO:0050905) | 2.86041940 |
| 101 | synaptic transmission (GO:0007268) | 2.84853374 |
| 102 | learning (GO:0007612) | 2.84438226 |
| 103 | fear response (GO:0042596) | 2.84025567 |
| 104 | response to auditory stimulus (GO:0010996) | 2.83295289 |
| 105 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.82501211 |
| 106 | auditory behavior (GO:0031223) | 2.82156624 |
| 107 | serotonin metabolic process (GO:0042428) | 2.81748485 |
| 108 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.77395114 |
| 109 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.77395114 |
| 110 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.77395114 |
| 111 | cAMP catabolic process (GO:0006198) | 2.74236044 |
| 112 | phospholipid translocation (GO:0045332) | 2.73948775 |
| 113 | lipid translocation (GO:0034204) | 2.73948775 |
| 114 | cyclic nucleotide catabolic process (GO:0009214) | 2.69531570 |
| 115 | primary amino compound metabolic process (GO:1901160) | 2.67670625 |
| 116 | detection of calcium ion (GO:0005513) | 2.66661744 |
| 117 | histone H3-K4 trimethylation (GO:0080182) | 2.64274978 |
| 118 | cell differentiation in hindbrain (GO:0021533) | 2.63782868 |
| 119 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.62691814 |
| 120 | neuronal action potential (GO:0019228) | 2.60990005 |
| 121 | negative regulation of neurotransmitter transport (GO:0051589) | 2.57880285 |
| 122 | startle response (GO:0001964) | 2.57745454 |
| 123 | urinary tract smooth muscle contraction (GO:0014848) | 2.56807704 |
| 124 | protein targeting to Golgi (GO:0000042) | 2.50835734 |
| 125 | interkinetic nuclear migration (GO:0022027) | 2.50552187 |
| 126 | cellular response to ethanol (GO:0071361) | 2.49408618 |
| 127 | negative T cell selection (GO:0043383) | 2.49132103 |
| 128 | behavioral response to nicotine (GO:0035095) | 2.40421051 |
| 129 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.38216401 |
| 130 | postsynaptic membrane organization (GO:0001941) | 2.37649073 |
| 131 | protein K48-linked deubiquitination (GO:0071108) | 2.35233131 |
| 132 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.33673010 |
| 133 | macroautophagy (GO:0016236) | 2.33099805 |
| 134 | pericardium development (GO:0060039) | 2.32578326 |
| 135 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.27922237 |
| 136 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.27596601 |
| 137 | presynaptic membrane assembly (GO:0097105) | 2.26743058 |
| 138 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.26721901 |
| 139 | positive T cell selection (GO:0043368) | 2.26656891 |
| 140 | negative thymic T cell selection (GO:0045060) | 2.26580745 |
| 141 | nerve growth factor signaling pathway (GO:0038180) | 2.22148387 |
| 142 | nucleus localization (GO:0051647) | 2.18136977 |
| 143 | relaxation of cardiac muscle (GO:0055119) | 2.17145906 |
| 144 | positive regulation of Rap GTPase activity (GO:0032854) | 2.15699565 |
| 145 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.13846535 |
| 146 | potassium ion transmembrane transport (GO:0071805) | 2.13040217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.68324034 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.37032629 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.91869604 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.89112786 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.82195607 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.78644387 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.57358441 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.57324840 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.57324840 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.53725606 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.41589834 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.40934025 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.40788853 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.39804472 |
| 15 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.38435480 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.35672433 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.29594794 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.24833026 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.18280049 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.14861926 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.07036750 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.06383439 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04643084 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.04066598 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.02303293 |
| 26 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.01476516 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.01086818 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.86789747 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.84878483 |
| 30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.84846139 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.84657860 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.82449742 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.78842154 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70505778 |
| 35 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.59070252 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57459109 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.53653649 |
| 38 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.51558716 |
| 39 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.49898232 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.45227503 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43989511 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43780987 |
| 43 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.41680260 |
| 44 | AR_19668381_ChIP-Seq_PC3_Human | 1.35667254 |
| 45 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34326210 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34113187 |
| 47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.33734000 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.32951824 |
| 49 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.31728287 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29533127 |
| 51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.29279334 |
| 52 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29090140 |
| 53 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.28455034 |
| 54 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.28033669 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27273284 |
| 56 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.26401390 |
| 57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23371541 |
| 58 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22914414 |
| 59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.22344990 |
| 60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22143082 |
| 61 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21332279 |
| 62 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21290366 |
| 63 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20861781 |
| 64 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20751771 |
| 65 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19544961 |
| 66 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19399300 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18942936 |
| 68 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17430987 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16777927 |
| 70 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.16583582 |
| 71 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16375078 |
| 72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16076753 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15707031 |
| 74 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15517466 |
| 75 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15459641 |
| 76 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14877883 |
| 77 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14813867 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14138498 |
| 79 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.14119405 |
| 80 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13594818 |
| 81 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.13252141 |
| 82 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13091702 |
| 83 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.12821448 |
| 84 | KDM2B_26808549_Chip-Seq_REH_Human | 1.10286964 |
| 85 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09301424 |
| 86 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09285439 |
| 87 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.09261934 |
| 88 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08807334 |
| 89 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.08296763 |
| 90 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06762475 |
| 91 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06616976 |
| 92 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06541307 |
| 93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06169214 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05939552 |
| 95 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.05560883 |
| 96 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.04049426 |
| 97 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03716127 |
| 98 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03004987 |
| 99 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02566644 |
| 100 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.02173644 |
| 101 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01685790 |
| 102 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00434450 |
| 103 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99876250 |
| 104 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99806988 |
| 105 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99688449 |
| 106 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99556174 |
| 107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99337715 |
| 108 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.98960388 |
| 109 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.98934003 |
| 110 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98703112 |
| 111 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98457319 |
| 112 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98271064 |
| 113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97909220 |
| 114 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97380497 |
| 115 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97137643 |
| 116 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.97066167 |
| 117 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96819632 |
| 118 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.95889847 |
| 119 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93448773 |
| 120 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93363628 |
| 121 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.92534244 |
| 122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90193050 |
| 123 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89860112 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89569708 |
| 125 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89417865 |
| 126 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89020728 |
| 127 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88487480 |
| 128 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88487480 |
| 129 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.87051696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.85707669 |
| 2 | MP0003880_abnormal_central_pattern | 4.36775929 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.25055174 |
| 4 | MP0004270_analgesia | 3.55278699 |
| 5 | MP0009046_muscle_twitch | 3.42155081 |
| 6 | MP0009745_abnormal_behavioral_response | 3.39824416 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.27357699 |
| 8 | MP0002064_seizures | 3.24459068 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.85274666 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.82747925 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.77334227 |
| 12 | MP0002272_abnormal_nervous_system | 2.65523494 |
| 13 | MP0001486_abnormal_startle_reflex | 2.55960779 |
| 14 | MP0002822_catalepsy | 2.53802483 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.48855902 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.34469624 |
| 17 | MP0008569_lethality_at_weaning | 2.28750735 |
| 18 | MP0004130_abnormal_muscle_cell | 2.18246570 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.17299959 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.05046165 |
| 21 | MP0002067_abnormal_sensory_capabilities | 2.03252063 |
| 22 | MP0002736_abnormal_nociception_after | 2.01617038 |
| 23 | MP0001440_abnormal_grooming_behavior | 1.99576565 |
| 24 | MP0002909_abnormal_adrenal_gland | 1.85007270 |
| 25 | MP0001970_abnormal_pain_threshold | 1.78959811 |
| 26 | MP0000569_abnormal_digit_pigmentation | 1.78941954 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.78367468 |
| 28 | MP0002184_abnormal_innervation | 1.74474460 |
| 29 | MP0004811_abnormal_neuron_physiology | 1.73674481 |
| 30 | MP0004924_abnormal_behavior | 1.70588695 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.70588695 |
| 32 | MP0003787_abnormal_imprinting | 1.67590661 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.67515513 |
| 34 | MP0008877_abnormal_DNA_methylation | 1.66040270 |
| 35 | MP0004858_abnormal_nervous_system | 1.65210884 |
| 36 | MP0005551_abnormal_eye_electrophysiolog | 1.64219501 |
| 37 | MP0003329_amyloid_beta_deposits | 1.61567468 |
| 38 | MP0004885_abnormal_endolymph | 1.55251177 |
| 39 | MP0003879_abnormal_hair_cell | 1.54639447 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.51180862 |
| 41 | MP0000778_abnormal_nervous_system | 1.50552367 |
| 42 | MP0001986_abnormal_taste_sensitivity | 1.49439645 |
| 43 | MP0000427_abnormal_hair_cycle | 1.47627618 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.47495324 |
| 45 | MP0001984_abnormal_olfaction | 1.45602864 |
| 46 | MP0000955_abnormal_spinal_cord | 1.44983849 |
| 47 | MP0000015_abnormal_ear_pigmentation | 1.44865094 |
| 48 | MP0002882_abnormal_neuron_morphology | 1.44161480 |
| 49 | MP0003633_abnormal_nervous_system | 1.43815508 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.40022493 |
| 51 | MP0004145_abnormal_muscle_electrophysio | 1.38145249 |
| 52 | MP0002066_abnormal_motor_capabilities/c | 1.37971111 |
| 53 | MP0002876_abnormal_thyroid_physiology | 1.35535167 |
| 54 | MP0003763_abnormal_thymus_physiology | 1.32896966 |
| 55 | MP0000751_myopathy | 1.21854373 |
| 56 | MP0003122_maternal_imprinting | 1.19903513 |
| 57 | MP0008961_abnormal_basal_metabolism | 1.19634796 |
| 58 | MP0003646_muscle_fatigue | 1.17963681 |
| 59 | MP0003631_nervous_system_phenotype | 1.17380985 |
| 60 | MP0002229_neurodegeneration | 1.13621404 |
| 61 | MP0003195_calcinosis | 1.13045319 |
| 62 | MP0004142_abnormal_muscle_tone | 1.10176279 |
| 63 | MP0006276_abnormal_autonomic_nervous | 1.09987260 |
| 64 | MP0005645_abnormal_hypothalamus_physiol | 1.09122024 |
| 65 | MP0002928_abnormal_bile_duct | 1.07654909 |
| 66 | MP0004215_abnormal_myocardial_fiber | 1.07372816 |
| 67 | MP0002152_abnormal_brain_morphology | 1.06855228 |
| 68 | MP0008057_abnormal_DNA_replication | 1.02592425 |
| 69 | MP0005310_abnormal_salivary_gland | 0.99895785 |
| 70 | MP0004233_abnormal_muscle_weight | 0.98651441 |
| 71 | MP0004084_abnormal_cardiac_muscle | 0.96687393 |
| 72 | MP0004085_abnormal_heartbeat | 0.96663366 |
| 73 | MP0002090_abnormal_vision | 0.94168553 |
| 74 | MP0003283_abnormal_digestive_organ | 0.94152203 |
| 75 | MP0003045_fibrosis | 0.93774029 |
| 76 | MP0000013_abnormal_adipose_tissue | 0.93206880 |
| 77 | MP0004510_myositis | 0.92537700 |
| 78 | MP0008872_abnormal_physiological_respon | 0.91252213 |
| 79 | MP0008874_decreased_physiological_sensi | 0.90796246 |
| 80 | MP0001177_atelectasis | 0.90547231 |
| 81 | MP0001188_hyperpigmentation | 0.89593783 |
| 82 | MP0002069_abnormal_eating/drinking_beha | 0.88677107 |
| 83 | MP0006072_abnormal_retinal_apoptosis | 0.85181700 |
| 84 | MP0004484_altered_response_of | 0.84311666 |
| 85 | MP0003632_abnormal_nervous_system | 0.84019539 |
| 86 | MP0002837_dystrophic_cardiac_calcinosis | 0.83028289 |
| 87 | MP0003690_abnormal_glial_cell | 0.80873962 |
| 88 | MP0002168_other_aberrant_phenotype | 0.80820723 |
| 89 | MP0004742_abnormal_vestibular_system | 0.80381395 |
| 90 | MP0001348_abnormal_lacrimal_gland | 0.80372121 |
| 91 | MP0005253_abnormal_eye_physiology | 0.80030073 |
| 92 | MP0010386_abnormal_urinary_bladder | 0.80029021 |
| 93 | MP0001299_abnormal_eye_distance/ | 0.79949905 |
| 94 | MP0003634_abnormal_glial_cell | 0.79042972 |
| 95 | MP0010234_abnormal_vibrissa_follicle | 0.77906612 |
| 96 | MP0002009_preneoplasia | 0.76351052 |
| 97 | MP0005623_abnormal_meninges_morphology | 0.76161020 |
| 98 | MP0004134_abnormal_chest_morphology | 0.75887369 |
| 99 | MP0003075_altered_response_to | 0.75568855 |
| 100 | MP0005535_abnormal_body_temperature | 0.75161009 |
| 101 | MP0002752_abnormal_somatic_nervous | 0.75090068 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.74828266 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.73206427 |
| 104 | MP0003137_abnormal_impulse_conducting | 0.72600908 |
| 105 | MP0005448_abnormal_energy_balance | 0.72563668 |
| 106 | MP0001905_abnormal_dopamine_level | 0.72262460 |
| 107 | MP0000920_abnormal_myelination | 0.71960711 |
| 108 | MP0001963_abnormal_hearing_physiology | 0.70232831 |
| 109 | MP0003724_increased_susceptibility_to | 0.69501045 |
| 110 | MP0004043_abnormal_pH_regulation | 0.68243264 |
| 111 | MP0000230_abnormal_systemic_arterial | 0.68089546 |
| 112 | MP0005499_abnormal_olfactory_system | 0.67591978 |
| 113 | MP0005394_taste/olfaction_phenotype | 0.67591978 |
| 114 | MP0005671_abnormal_response_to | 0.64694739 |
| 115 | MP0000604_amyloidosis | 0.64625661 |
| 116 | MP0004036_abnormal_muscle_relaxation | 0.63612182 |
| 117 | MP0004381_abnormal_hair_follicle | 0.62786425 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.62404930 |
| 119 | MP0005187_abnormal_penis_morphology | 0.60349530 |
| 120 | MP0001529_abnormal_vocalization | 0.59886406 |
| 121 | MP0000631_abnormal_neuroendocrine_gland | 0.59122817 |
| 122 | MP0002638_abnormal_pupillary_reflex | 0.58315184 |
| 123 | MP0010769_abnormal_survival | 0.57673848 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.56873694 |
| 125 | MP0001943_abnormal_respiration | 0.55500220 |
| 126 | MP0001485_abnormal_pinna_reflex | 0.54306967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.32328069 |
| 2 | Myokymia (HP:0002411) | 5.97280225 |
| 3 | Focal seizures (HP:0007359) | 5.71064289 |
| 4 | Visual hallucinations (HP:0002367) | 5.10995658 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 4.77927671 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.77169153 |
| 7 | Febrile seizures (HP:0002373) | 4.73898858 |
| 8 | Action tremor (HP:0002345) | 4.43704700 |
| 9 | Atonic seizures (HP:0010819) | 4.42551878 |
| 10 | Absence seizures (HP:0002121) | 4.12006039 |
| 11 | Gaze-evoked nystagmus (HP:0000640) | 3.81596820 |
| 12 | Dialeptic seizures (HP:0011146) | 3.69116156 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.66769913 |
| 14 | Broad-based gait (HP:0002136) | 3.55887360 |
| 15 | Dysdiadochokinesis (HP:0002075) | 3.49937152 |
| 16 | Genetic anticipation (HP:0003743) | 3.46879303 |
| 17 | Truncal ataxia (HP:0002078) | 3.32783411 |
| 18 | Poor eye contact (HP:0000817) | 3.29025063 |
| 19 | Dysmetric saccades (HP:0000641) | 3.25855495 |
| 20 | Depression (HP:0000716) | 3.20251322 |
| 21 | Supranuclear gaze palsy (HP:0000605) | 3.18948224 |
| 22 | Impaired social interactions (HP:0000735) | 3.16008353 |
| 23 | Abnormal social behavior (HP:0012433) | 3.16008353 |
| 24 | Impaired smooth pursuit (HP:0007772) | 3.15717889 |
| 25 | Dysmetria (HP:0001310) | 3.12939366 |
| 26 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.09757768 |
| 27 | Postural instability (HP:0002172) | 3.01251807 |
| 28 | Hemiplegia (HP:0002301) | 3.00149390 |
| 29 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.99113491 |
| 30 | Scanning speech (HP:0002168) | 2.95043739 |
| 31 | Clumsiness (HP:0002312) | 2.87308087 |
| 32 | Ankle clonus (HP:0011448) | 2.85323182 |
| 33 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.82008184 |
| 34 | Hyperventilation (HP:0002883) | 2.80229981 |
| 35 | Widely spaced teeth (HP:0000687) | 2.79141734 |
| 36 | Fair hair (HP:0002286) | 2.78995873 |
| 37 | Papilledema (HP:0001085) | 2.74565970 |
| 38 | Generalized hypopigmentation of hair (HP:0011358) | 2.74423439 |
| 39 | Anxiety (HP:0000739) | 2.68747835 |
| 40 | Abnormality of the lower motor neuron (HP:0002366) | 2.68452690 |
| 41 | Drooling (HP:0002307) | 2.60509184 |
| 42 | Excessive salivation (HP:0003781) | 2.60509184 |
| 43 | Intention tremor (HP:0002080) | 2.57060316 |
| 44 | Abnormal eating behavior (HP:0100738) | 2.56276182 |
| 45 | Hemiparesis (HP:0001269) | 2.54941450 |
| 46 | Diplopia (HP:0000651) | 2.53024967 |
| 47 | Abnormality of binocular vision (HP:0011514) | 2.53024967 |
| 48 | Ventricular fibrillation (HP:0001663) | 2.52677601 |
| 49 | Central scotoma (HP:0000603) | 2.47626123 |
| 50 | Inability to walk (HP:0002540) | 2.47063277 |
| 51 | Amblyopia (HP:0000646) | 2.46819253 |
| 52 | Stereotypic behavior (HP:0000733) | 2.46111039 |
| 53 | Urinary urgency (HP:0000012) | 2.42944971 |
| 54 | T lymphocytopenia (HP:0005403) | 2.42608611 |
| 55 | Mutism (HP:0002300) | 2.41909498 |
| 56 | Status epilepticus (HP:0002133) | 2.34266996 |
| 57 | Abnormality of T cell number (HP:0011839) | 2.29705602 |
| 58 | Epileptiform EEG discharges (HP:0011182) | 2.28193558 |
| 59 | Pointed chin (HP:0000307) | 2.24907027 |
| 60 | Bradykinesia (HP:0002067) | 2.24618698 |
| 61 | Spastic gait (HP:0002064) | 2.24193819 |
| 62 | Absent speech (HP:0001344) | 2.23023113 |
| 63 | Bundle branch block (HP:0011710) | 2.22393531 |
| 64 | Congenital stationary night blindness (HP:0007642) | 2.17862298 |
| 65 | Torticollis (HP:0000473) | 2.17795825 |
| 66 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17779802 |
| 67 | Impaired vibratory sensation (HP:0002495) | 2.16915787 |
| 68 | Annular pancreas (HP:0001734) | 2.16869264 |
| 69 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.15168076 |
| 70 | Thyroiditis (HP:0100646) | 2.10473281 |
| 71 | Macroorchidism (HP:0000053) | 2.08844807 |
| 72 | Abnormality of the renal cortex (HP:0011035) | 2.03182548 |
| 73 | Hypsarrhythmia (HP:0002521) | 2.03047895 |
| 74 | Insomnia (HP:0100785) | 2.01496067 |
| 75 | Progressive inability to walk (HP:0002505) | 2.00054619 |
| 76 | Macroglossia (HP:0000158) | 1.99952382 |
| 77 | Agitation (HP:0000713) | 1.99914263 |
| 78 | Abnormal EKG (HP:0003115) | 1.97887486 |
| 79 | Focal dystonia (HP:0004373) | 1.97144306 |
| 80 | Termporal pattern (HP:0011008) | 1.96803046 |
| 81 | Insidious onset (HP:0003587) | 1.96803046 |
| 82 | Prolonged QT interval (HP:0001657) | 1.96023296 |
| 83 | Abnormality of saccadic eye movements (HP:0000570) | 1.95413880 |
| 84 | Megalencephaly (HP:0001355) | 1.94448187 |
| 85 | Attenuation of retinal blood vessels (HP:0007843) | 1.93534354 |
| 86 | Gait ataxia (HP:0002066) | 1.92246622 |
| 87 | Abnormality of macular pigmentation (HP:0008002) | 1.91730750 |
| 88 | Narrow palate (HP:0000189) | 1.90652379 |
| 89 | Pancreatic cysts (HP:0001737) | 1.89259748 |
| 90 | Short chin (HP:0000331) | 1.87827613 |
| 91 | Lower limb muscle weakness (HP:0007340) | 1.87220397 |
| 92 | Bulbous nose (HP:0000414) | 1.86623610 |
| 93 | Abnormality of the fingertips (HP:0001211) | 1.86548397 |
| 94 | Neoplasm of the heart (HP:0100544) | 1.85237970 |
| 95 | Blue irides (HP:0000635) | 1.85159884 |
| 96 | Decreased circulating renin level (HP:0003351) | 1.84802053 |
| 97 | Slow saccadic eye movements (HP:0000514) | 1.84767982 |
| 98 | Ocular albinism (HP:0001107) | 1.84734040 |
| 99 | Neonatal hypoglycemia (HP:0001998) | 1.84703314 |
| 100 | Stomach cancer (HP:0012126) | 1.84189224 |
| 101 | Limb dystonia (HP:0002451) | 1.83163255 |
| 102 | Pheochromocytoma (HP:0002666) | 1.82440727 |
| 103 | Aqueductal stenosis (HP:0002410) | 1.81601610 |
| 104 | Atrial fibrillation (HP:0005110) | 1.81221168 |
| 105 | Lower limb asymmetry (HP:0100559) | 1.81087702 |
| 106 | Exotropia (HP:0000577) | 1.80165474 |
| 107 | Postural tremor (HP:0002174) | 1.78820232 |
| 108 | Tented upper lip vermilion (HP:0010804) | 1.78781856 |
| 109 | Fetal akinesia sequence (HP:0001989) | 1.78557534 |
| 110 | Lower limb amyotrophy (HP:0007210) | 1.77602829 |
| 111 | Hematochezia (HP:0002573) | 1.77429362 |
| 112 | Neuronal loss in central nervous system (HP:0002529) | 1.77049046 |
| 113 | Inappropriate behavior (HP:0000719) | 1.76154580 |
| 114 | Generalized myoclonic seizures (HP:0002123) | 1.75599338 |
| 115 | Syncope (HP:0001279) | 1.75438888 |
| 116 | Incomplete penetrance (HP:0003829) | 1.75329495 |
| 117 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.74652422 |
| 118 | Scotoma (HP:0000575) | 1.74605095 |
| 119 | Cerebral inclusion bodies (HP:0100314) | 1.73803765 |
| 120 | Primary atrial arrhythmia (HP:0001692) | 1.73755718 |
| 121 | Abnormal drinking behavior (HP:0030082) | 1.73697932 |
| 122 | Polydipsia (HP:0001959) | 1.73697932 |
| 123 | Type II lissencephaly (HP:0007260) | 1.73553879 |
| 124 | Abnormality of the corticospinal tract (HP:0002492) | 1.72734253 |
| 125 | Hypoventilation (HP:0002791) | 1.72727786 |
| 126 | Spinal canal stenosis (HP:0003416) | 1.71848052 |
| 127 | Obstructive sleep apnea (HP:0002870) | 1.71655967 |
| 128 | Nephronophthisis (HP:0000090) | 1.71047919 |
| 129 | Abnormality of the nasal septum (HP:0000419) | 1.69627282 |
| 130 | Psychosis (HP:0000709) | 1.68714915 |
| 131 | Tapered finger (HP:0001182) | 1.67952537 |
| 132 | Abnormality of the renal medulla (HP:0100957) | 1.67949515 |
| 133 | Molar tooth sign on MRI (HP:0002419) | 1.66102108 |
| 134 | Abnormality of midbrain morphology (HP:0002418) | 1.66102108 |
| 135 | Craniofacial dystonia (HP:0012179) | 1.65906482 |
| 136 | Resting tremor (HP:0002322) | 1.65885943 |
| 137 | Protruding tongue (HP:0010808) | 1.65872594 |
| 138 | Stomatitis (HP:0010280) | 1.62959781 |
| 139 | Dyskinesia (HP:0100660) | 1.61680565 |
| 140 | Iris hypopigmentation (HP:0007730) | 1.60094376 |
| 141 | Abnormality of the columella (HP:0009929) | 1.58157018 |
| 142 | Chronic hepatic failure (HP:0100626) | 1.56775046 |
| 143 | Pancreatic fibrosis (HP:0100732) | 1.54774101 |
| 144 | Intellectual disability, severe (HP:0010864) | 1.54211961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.32377302 |
| 2 | NTRK3 | 4.93974897 |
| 3 | EPHA4 | 3.85260957 |
| 4 | MAP3K9 | 3.69690666 |
| 5 | MAP3K4 | 3.08127020 |
| 6 | TAOK3 | 2.55781776 |
| 7 | MINK1 | 2.42183512 |
| 8 | DAPK2 | 2.40735236 |
| 9 | PAK6 | 2.34391689 |
| 10 | MAP2K7 | 2.30147008 |
| 11 | MARK1 | 2.23346157 |
| 12 | PRKD3 | 2.14781355 |
| 13 | CAMKK1 | 2.09757953 |
| 14 | NTRK2 | 2.07141580 |
| 15 | KSR2 | 2.02367695 |
| 16 | TNIK | 1.91065776 |
| 17 | RIPK4 | 1.89862876 |
| 18 | MAP2K4 | 1.82549323 |
| 19 | NTRK1 | 1.58327803 |
| 20 | KSR1 | 1.53020178 |
| 21 | PRPF4B | 1.51299344 |
| 22 | CDK5 | 1.49227665 |
| 23 | SIK2 | 1.48153292 |
| 24 | CAMKK2 | 1.45841134 |
| 25 | TXK | 1.45474192 |
| 26 | DAPK1 | 1.43112464 |
| 27 | MAP3K12 | 1.35936038 |
| 28 | PNCK | 1.33997614 |
| 29 | ACVR1B | 1.32611405 |
| 30 | MAP3K13 | 1.28796933 |
| 31 | PRKCH | 1.23427728 |
| 32 | MAP3K2 | 1.22547910 |
| 33 | PLK2 | 1.21539798 |
| 34 | FES | 1.21244666 |
| 35 | TYRO3 | 1.18445156 |
| 36 | SGK2 | 1.17400257 |
| 37 | PRKCG | 1.15534214 |
| 38 | SGK3 | 1.15523437 |
| 39 | CAMK1G | 1.14538601 |
| 40 | CAMK1 | 1.13958317 |
| 41 | NLK | 1.13529844 |
| 42 | ADRBK2 | 1.13405876 |
| 43 | JAK1 | 1.12927100 |
| 44 | RIPK1 | 1.12817034 |
| 45 | CASK | 1.11645277 |
| 46 | SGK494 | 1.10581253 |
| 47 | SGK223 | 1.10581253 |
| 48 | TAOK1 | 1.10451748 |
| 49 | MAPK13 | 1.08716474 |
| 50 | GRK5 | 1.08192950 |
| 51 | CDK19 | 1.05738713 |
| 52 | BMPR1B | 1.03944453 |
| 53 | PIK3CA | 1.03456895 |
| 54 | STK11 | 1.02898591 |
| 55 | WNK1 | 1.02439774 |
| 56 | TRPM7 | 0.99770432 |
| 57 | RET | 0.96888550 |
| 58 | CAMK2A | 0.93320028 |
| 59 | UHMK1 | 0.92880631 |
| 60 | ITK | 0.92843125 |
| 61 | MAP3K7 | 0.89370107 |
| 62 | FGFR3 | 0.87850526 |
| 63 | CDK12 | 0.87844890 |
| 64 | SGK1 | 0.87414201 |
| 65 | PHKG1 | 0.87103747 |
| 66 | PHKG2 | 0.87103747 |
| 67 | LMTK2 | 0.84526963 |
| 68 | STK39 | 0.84205029 |
| 69 | ALK | 0.84196565 |
| 70 | PAK3 | 0.82502388 |
| 71 | PDK1 | 0.82268828 |
| 72 | GRK1 | 0.81344938 |
| 73 | CDC42BPA | 0.79340208 |
| 74 | MARK2 | 0.79091841 |
| 75 | TEC | 0.78615398 |
| 76 | DMPK | 0.75573928 |
| 77 | PTK2B | 0.75167911 |
| 78 | PINK1 | 0.74559865 |
| 79 | CDK18 | 0.74521031 |
| 80 | CDK15 | 0.74060801 |
| 81 | TNK2 | 0.73908713 |
| 82 | * STK38 | 0.73520665 |
| 83 | INSRR | 0.73478634 |
| 84 | WNK4 | 0.73107613 |
| 85 | SYK | 0.72797720 |
| 86 | RAF1 | 0.71448599 |
| 87 | CAMK2B | 0.70465731 |
| 88 | CAMK4 | 0.69210708 |
| 89 | PDGFRB | 0.68363558 |
| 90 | CDK14 | 0.68086820 |
| 91 | ARAF | 0.67894897 |
| 92 | ADRBK1 | 0.67672379 |
| 93 | PDPK1 | 0.67234597 |
| 94 | MAP3K1 | 0.63617368 |
| 95 | DYRK1A | 0.63600908 |
| 96 | LATS2 | 0.63018917 |
| 97 | ZAP70 | 0.62640014 |
| 98 | CDK11A | 0.62251617 |
| 99 | RPS6KA3 | 0.60637783 |
| 100 | HIPK2 | 0.55655589 |
| 101 | MAPK7 | 0.55455372 |
| 102 | CAMK2D | 0.55437294 |
| 103 | OXSR1 | 0.54922233 |
| 104 | MAPK10 | 0.53617790 |
| 105 | LCK | 0.53541698 |
| 106 | MAP4K1 | 0.52767206 |
| 107 | NEK6 | 0.52650120 |
| 108 | SCYL2 | 0.51482842 |
| 109 | FYN | 0.51373163 |
| 110 | FGFR2 | 0.50998819 |
| 111 | BMPR2 | 0.50565470 |
| 112 | FER | 0.49681011 |
| 113 | PIK3CG | 0.49231070 |
| 114 | PRKCQ | 0.48924831 |
| 115 | GRK6 | 0.46823523 |
| 116 | AKT3 | 0.45878416 |
| 117 | IKBKE | 0.45446003 |
| 118 | CSNK1G2 | 0.45177829 |
| 119 | PRKCZ | 0.43813018 |
| 120 | PRKCE | 0.43203846 |
| 121 | PRKAA2 | 0.42244969 |
| 122 | HCK | 0.41749311 |
| 123 | PRKAA1 | 0.40651255 |
| 124 | LATS1 | 0.40277861 |
| 125 | MELK | 0.39872713 |
| 126 | ERBB2 | 0.39587574 |
| 127 | MAP2K1 | 0.38795738 |
| 128 | CAMK2G | 0.38689804 |
| 129 | PDGFRA | 0.38207976 |
| 130 | WNK3 | 0.37449136 |
| 131 | MARK3 | 0.37268479 |
| 132 | * PRKCB | 0.37071562 |
| 133 | MAP4K2 | 0.36618940 |
| 134 | CAMK1D | 0.36151249 |
| 135 | MAPK12 | 0.34007073 |
| 136 | PRKD2 | 0.33900776 |
| 137 | ROCK2 | 0.33857204 |
| 138 | PRKG1 | 0.32292196 |
| 139 | NEK1 | 0.31993091 |
| 140 | RPS6KA2 | 0.30736751 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.46890722 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.94988399 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.62856014 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.61958333 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.54578820 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.52057960 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50363590 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.49242044 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.35495940 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.28477065 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.13616767 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.13242637 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.04480618 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.98978310 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.88290779 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.87339430 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.83702685 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.69260630 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.65706786 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.65120363 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.64860768 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.64205669 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.57418631 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.54436843 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.53909805 |
| 26 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.45038339 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.44249860 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.42212171 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.40899117 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35339299 |
| 31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.34086370 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32729289 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.24150170 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.22249324 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.21389338 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.17198472 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16338791 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16337991 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05738640 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.05725748 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.02889844 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02358386 |
| 43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01840212 |
| 44 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.98920786 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.98182791 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 0.97761127 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96556316 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.95555674 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94855819 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93002098 |
| 51 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90660503 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 0.89708042 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87605955 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84778373 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80954110 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80852022 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80764838 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79882935 |
| 59 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77296684 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77226056 |
| 61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77026356 |
| 62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76935517 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.76159219 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76116166 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75524170 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73246212 |
| 67 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.71658281 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71055251 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69685843 |
| 70 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69321395 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69303362 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67984132 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66069726 |
| 74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64044100 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62824519 |
| 76 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59463562 |
| 77 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59302546 |
| 78 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57669279 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57037038 |
| 80 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56654049 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56630622 |
| 82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55896428 |
| 83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54155197 |
| 84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53786771 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52498373 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.50964742 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49990016 |
| 88 | Bile secretion_Homo sapiens_hsa04976 | 0.48663483 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47810458 |
| 90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.47150863 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47034840 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.46786620 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46749952 |
| 94 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46674513 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45977110 |
| 96 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.45752993 |
| 97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45727352 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.45118737 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44722025 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44084230 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43853807 |
| 102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43630369 |
| 103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43306896 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42420244 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41612564 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41352715 |
| 107 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41235607 |
| 108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36971438 |
| 109 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36807976 |
| 110 | Alcoholism_Homo sapiens_hsa05034 | 0.36398747 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35785131 |
| 112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35767274 |
| 113 | Platelet activation_Homo sapiens_hsa04611 | 0.34142176 |
| 114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33930342 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31816537 |
| 116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.31146444 |
| 117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30855657 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29684052 |
| 119 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.28496003 |
| 120 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27239059 |

